Report Surveys Unmet Needs and Attitudes of People Living with RA
Research Partnership's new report on living with rheumatoid arthritis (RA) is aimed at "helping pharmaceutical companies understand the attitudes and unmet needs of people with RA and how current market dynamics, with the advent of new biologics/biosimilars and oral JAK inhibitors, have affected patients’ views and behaviours towards their RA". Living with Rheumatoid Arthritis (RA) is based on 431 patients diagnosed with RA in the 5 EU markets (France, Germany, Italy, Spain, UK), 56 patients in Japan, and 112 patients in Canada. The study consists of 30-minute quantitative online and qualitative telephone interviews with patients. Research Partnership's Mariel Metcalfe commented: “An inescapable characteristic of RA is that it is unpredictable and can highly impact patients’ practical and emotional lives. While the range of RA treatments has grown, it is even more important to understand and measure how patients view these treatments and if they are truly meeting their needs.” Living with RA is one in a series of "Living With" reports offering insight into the chronic disease patient journey from pre-diagnosis to stabilization, which include Atopic Dermatitis (EU & US), Psoriasis (EU), NASH (EU & US) and Diabetes LATAM. www.researchpartnership.com/livingwith
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.
